Search results
Results from the WOW.Com Content Network
It's important to understand why teens use or misuse drugs, so the right resources and education can help them, Dr. Nora Volkow, director of the National Institute on Drug Abuse, wrote in an email.
English: A rational scale to assess the harm of drugs. Data source is the March 24, 2007 article: Nutt, David, Leslie A King, William Saulsbury, Colin Blakemore. "Development of a rational scale to assess the harm of drugs of potential misuse" The Lancet 2007; 369:1047-1053.
It surveys students in grades 9–12 at their high schools. [2] [3] It is one of the major sources of information about these risk behaviors, and is used by federal agencies to track drug use, sexual behavior, and other risk behaviors. The YRBSS was created in 1990 [2] in order to monitor progress towards protecting youth from HIV infection.
For drug use specifically, studies show that more than half of high school seniors have used an illegal drug of any kind and a fourth have used illegal drugs other than marijuana. [7] [8] In addition, more than two-thirds of high school seniors, half of sophomores, and a third of eighth graders have used alcohol in the past year. [8]
Supporting and improving mental health could have a direct impact on substance use among teens in the United States, according to a new study from the US Centers for Disease Control and Prevention.
The drugs dispensed by these programs can result in intoxication, unlike methadone or buprenorphine. [98] Safer supply projects exist in a number of Canadian cities. [84] Critics of these programs point to the risk of drug diversion and argue that patients should be encouraged to enter drug rehabilitation programs instead of being given drugs. [98]
Psychosis risk increases 81% on high-dose amphetamine For this study, researchers analyzed medical data from adults between the ages of 16 and 35 treated at Mass General Brigham between 2005 and 2019.
Risk Evaluation and Mitigation Strategies (REMS) is a program of the US Food and Drug Administration for the monitoring of medications with a high potential for serious adverse effects. REMS applies only to specific prescription drugs, but can apply to brand name or generic drugs. [1] The REMS program was formalized in 2007.